AAAAAA
Results:
1-12
|
Results: 12
Authors:
Dahlin, M
Jansson, B
Bjork, E
Citation: M. Dahlin et al., Levels of dopamine in blood and brain following nasal administration to rats, EUR J PH SC, 14(1), 2001, pp. 75-80
Authors:
Torn, C
Landin-Olsson, M
Lernmark, A
Schersten, B
Ostman, J
Arnqvist, HJ
Bjork, E
Blohme, G
Bolinder, J
Eriksson, J
Littorin, B
Nystrom, L
Sundkvist, G
Citation: C. Torn et al., Combinations of beta cell specific autoantibodies at diagnosis of diabetesin young adults reflects different courses of beta cell damage, AUTOIMMUN, 33(2), 2001, pp. 115-120
Authors:
Dahlin, M
Bjork, E
Citation: M. Dahlin et E. Bjork, Nasal administration of a physostigmine analogue (NXX-066) for Alzheimer'sdisease to rats, INT J PHARM, 212(2), 2001, pp. 267-274
Authors:
Littorin, B
Bjork, E
Sundkvist, G
Blohme, G
Nystrom, L
Bolinder, J
Carlson, A
Eriksson, JW
Landin-Olsson, M
Schersten, B
Ostman, J
Wibell, L
Arnqvist, HJ
Citation: B. Littorin et al., Family characteristics and life events before the onset of autoimmune type1 diabetes in young adults - A nationwide study, DIABET CARE, 24(6), 2001, pp. 1033-1037
Authors:
Torn, C
Landin-Olsson, M
Ostman, J
Schersten, B
Arnqvist, H
Blohme, G
Bjork, E
Bolinder, J
Eriksson, J
Littorin, B
Nystrom, L
Sundkvist, G
Lernmark, A
Citation: C. Torn et al., Glutamic acid decarboxylase antibodies (GADA) is the most important factorfor prediction of insulin therapy within 3 years in young adult diabetic patients not classified as Type 1 diabetes on clinical grounds, DIABET M R, 16(6), 2000, pp. 442-447
Authors:
Ostman, J
Landin-Olsson, M
Torn, C
Palmer, J
Lernmark, A
Arnqvist, H
Bjork, E
Bolinder, J
Blohme, G
Eriksson, J
Littorin, B
Nystrom, L
Schersten, B
Sundkvist, G
Wibell, L
Citation: J. Ostman et al., Ketoacidosis in young adults is not related to the islet antibodies at thediagnosis of Type 1 diabetes mellitus - a nationwide study, DIABET MED, 17(4), 2000, pp. 269-274
Authors:
Dahlin, M
Bergman, U
Jansson, B
Bjork, E
Brittebo, E
Citation: M. Dahlin et al., Transfer of dopamine in the olfactory pathway following nasal administration in mice, PHARM RES, 17(6), 2000, pp. 737-742
Authors:
Dahlin, M
Bjork, E
Citation: M. Dahlin et E. Bjork, Nasal absorption of (S)-UH-301 and its transport into the cerebrospinal fluid of rats, INT J PHARM, 195(1-2), 2000, pp. 197-205
Authors:
Bjork, E
Nevalainen, T
Hakumaki, M
Voipio, HM
Citation: E. Bjork et al., R-weighting provides better estimation for rat hearing sensitivity, LAB ANIMALS, 34(2), 2000, pp. 136-144
Authors:
Kullin, M
Li, ZC
Hansen, JB
Bjork, E
Sandler, S
Karlsson, FA
Citation: M. Kullin et al., K-ATP channel openers protect rat islets against the toxic effect of streptozotocin, DIABETES, 49(7), 2000, pp. 1131-1136
Authors:
Scholin, A
Berne, C
Schvarcz, E
Karlsson, FA
Bjork, E
Citation: A. Scholin et al., Factors predicting clinical remission in adult patients with type 1 diabetes, J INTERN M, 245(2), 1999, pp. 155-162
Authors:
Wadell, C
Bjork, E
Camber, O
Citation: C. Wadell et al., Nasal drug delivery - evaluation of an in vitro model using porcine nasal mucosa, EUR J PH SC, 7(3), 1999, pp. 197-206
Risultati:
1-12
|